Printer Friendly

Protease inhibitors November 1996: Jon Barrett describes the impact of a New York Times story heralding the drugs. (Bold beginnings).

I've never fully understood the scientific intricacies of HIV infection and AIDS. But growing up in the 1980s and coming out in the 1990s, as I did, I've always known enough to understand the despair of older friends who lost so many loved ones to the disease. Enough to recognize that I would be forced to share in that despair. Enough to be afraid.

Similarly, I didn't fully comprehend reports out of Vancouver, Canada, in 1996 that chronicled the success of a new class of drugs called protease inhibitors.

Then one Sunday morning at a coffee shop in the heart of Chicago's Boystown, I read Andrew Sullivan's November 10, 1996, New York Times Magazine cover story, "When Plagues End." He described friends who months before had been "hobbling along, their cheekbones poking out of their skin, their eyes deadened and looking down." Upon taking these new drugs, they "were suddenly restored into some strange spectacle of health, gazing around as amazed as I was to see them alive."

On combination therapy himself, Sullivan wrote that he now lived "with the expectation that life is not immediately fragile; that if I push it, it will not break." For me and many others, the essay was an introduction to the so-called drug cocktail and the ways it could change the lives of people with HIV.

In the months and years since, Sullivan has taken heat from some people for painting too bright a picture. The name of his essay, for example, suggested a conclusion to the crisis that researchers today aren't ready to project for 20 years in the future. Still, on that Sunday in November, his New York Times story helped me understand something about HIV and AIDS that science alone had yet to--that there is hope.
COPYRIGHT 2002 Liberation Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Author:Barrett, Jon
Publication:The Advocate (The national gay & lesbian newsmagazine)
Date:Nov 12, 2002
Words:296
Previous Article:k.d. lang June 1992: Dan Mathews notes that K.D. Lang came out as a lesbian only after first coming out as vegetarian. (Bold beginnings).
Next Article:Melissa Etheridge January 1993: no orchestrated coming-out for this rocker. She just says, "yes I am". (Rebels & Pioneers).


Related Articles
Protease inhibitors turn 1.
The good news: protease inhibitors.
Community Update: New Drugs to Watch.
Protease inhibitors in children: combination therapy reduced death by two thirds.
FEWER SUCCUMB TO AIDS IN U.S.; COUNTY DEATHS ALSO DECREASE.
AIDS DRUGS FAILING FOR HALF OF PATIENTS.
Protease inhibitor combination therapy and decreased condom use among gay men.
Drug disables enzyme from hepatitis C virus.
Integrase inhibitors: first clear success in human trial.
The next line of attack: the previous generation of anti-HIV drugs changed AIDS from an untreatable epidemic into a survivable disease. The next crop...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters